Xu, J., Zhang, Y., Lin, R., Qian, X., Zhang, W., Liu, C., Zhang, X., Zhang, J., Zhang, H., Li, B., Li, S., Liu, H., Zhao, J., Li, J., Lu, L., Sun, M., Cai, J., An, H., Zhou, P., Huang, S. (2026). Phase 3, multicenter, randomized, controlled open-label study: Efficacy and safety of M701 (EpCAM×CD3 bispecific antibody) intraperitoneal infusion in advanced epithelial solid tumor with malignant ascites vs paracentesis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.104